Medlab Clinical

Medlab Clinical Dividend

Delisted

Dividend of Medlab Clinical (MDC.AX) as of Oct 19, 2026.

Dividend

0.00AUD

Last updated:

How much dividend does Medlab Clinical 2026 pay?

According to the latest status from October 2026, Medlab Clinical paid a total of 0.00 AUD per share in dividends within the last 12 months. With the current Medlab Clinical price of 6.60 AUD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Medlab Clinical Dividends

Historical Medlab Clinical Dividends
PaydateDividend

The Medlab Clinical Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2020
0.00 AUD
Jan 1, 2021
0.00 AUD
Jan 1, 2022
0.00 AUD
Jan 1, 2023
0.00 AUD
Jan 1, 2024
0.00 AUD
Jan 1, 2025 (e)
0.00 AUD
Jan 1, 2026 (e)
0.00 AUD
Jan 1, 2027 (e)
0.00 AUD
The Medlab Clinical Dividend history
YEARDividendYoY
est0.00AUD—
est0.00AUD—
est0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—

Is the Medlab Clinical Dividend Safe?

Medlab Clinical has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Medlab Clinical's Dividend Distributions

Medlab Clinical’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Medlab Clinical's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Medlab Clinical's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Medlab Clinical’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Medlab Clinical Stock analysis

What does Medlab Clinical do? Medlab Clinical Ltd is an innovative biotechnology company focused on the development and commercialization of medical products and services. The company was founded in Australia in 2012 and is now based in Sydney. Since its founding, Medlab has established itself as a leading provider of diagnostic and therapeutic products. Medlab's business model consists of three different divisions. The first division is pharmaceutical development, where Medlab works on the development of new medications for the treatment of conditions such as fibromyalgia, pain, or ADHD. Medlab is particularly innovative in the development of medications based on the use of cannabinoids that are approved for medical use. The second division of Medlab is the research and development of nutritional supplements. The company works on the development of innovative products to improve general well-being and support health. An example is the nutritional supplement NRGBiotic, which contains special probiotic bacteria that help regulate the intestinal flora and thereby strengthen the immune system. The third division of Medlab is clinical diagnostics. The company offers various medical diagnostic tests, such as the test for food intolerances. This test is based on a blood sample and allows for targeted dietary changes in individuals with intolerance. Medlab aims to improve people's lives by developing and providing innovative products and services for medical care. Medlab's products are designed to promote the health and well-being of patients and customers and improve their quality of life. One outstanding product from Medlab is NanoCBD, an innovative form of cannabinoid delivery for medical purposes. The advantage of NanoCBD is that it has increased bioavailability due to the nanoparticles, resulting in faster and more effective action than conventional CBD products. Another product from Medlab is the pain medication NanaBis, which works faster and more effectively than other pain medications due to its unique formulation. Thanks to its special composition, NanaBis can also be taken by patients with severe chronic pain who do not respond to other pain medications. Medlab has established itself as a global company and is present worldwide. The company maintains partnerships and collaborations with renowned research institutions and doctors in Europe, North America, Australia, and Asia. Medlab works closely with medical professionals to ensure that the company's products and services meet the highest quality standards and meet the needs of patients and customers. Overall, Medlab Clinical Ltd has established itself as an innovative and reliable company in the medical industry. With its clear focus on the development of innovative medications, nutritional supplements, and diagnostic systems, Medlab significantly contributes to improving the healthcare system and increasing the well-being of people worldwide. Medlab Clinical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medlab Clinical stock

Medlab Clinical paid dividends every year for the past 0 years.

Medlab Clinical is assigned to the 'Health' sector.

The dividends of Medlab Clinical are distributed in AUD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Medlab Clinical